Click “Register” to access recording
Recorded on 5/12/2025.
Speaker: Raphael Landovitz, MD, MSc
Description: This presentation explores the evolution and impact of HIV pre-exposure prophylaxis (PrEP), highlighting key developments in oral and long-acting injectable options, clinical trial insights, and adherence strategies. It also examines current and emerging prevention tools—including lenacapavir, islatravir, and antibody-based approaches—while addressing testing protocols, monitoring challenges, and global implementation considerations.
No Accreditation for Recorded or Archived events.
